SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-23-054354
Filing Date
2023-05-01
Accepted
2023-05-01 16:08:24
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2314210d3_defa14a.htm DEFA14A 12337
2 GRAPHIC tm2314210d3_defa14aimg001.jpg GRAPHIC 172544
3 GRAPHIC tm2314210d3_defa14aimg002.jpg GRAPHIC 119105
  Complete submission text file 0001104659-23-054354.txt   415328
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36306 | Film No.: 23873650
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences